We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Medical Students Trained in Genomics and Personalized Medicine

By LabMedica International staff writers
Posted on 14 Jul 2010
Doctors have recommended that genomics and personalized medicine become a core competency for all pathology trainees by 2012.

As a first step in leading this program, the department of pathology at Beth Israel Deaconess Medical Center (BIDMC; Boston, MA; USA) in collaboration with BIDMC's genetic counseling service, last year launched the Genomic Medicine Initiative, a compulsory program to prepare doctors-in-training to apply genomics and personalized medicine in their day-to-day practices.

Jeffrey Saffitz, M.D., Ph.D., and colleagues wrote in a special article in the June, 2010 edition of the American Journal Of Clinical Pathology (AJCP), "Genomics and 'medical sequencing' will revolutionize clinical laboratory diagnostics as the foundation for the new era of personalized medicine.....Pathologists must take the lead in the application of genomics technologies, including whole genome sequencing, laboratory technologies, and personalized medicine."

The new BIDMC pathology curriculum addresses these issues, with the new medical specialty built on three pillars: laboratory medicine, genetic counseling, and health information technology. More...
Richard Schwartzstein, M.D., vice president for education at BIDMC and a faculty dean for medical education at Harvard Medical School (Boston, MA, USA), explained, "The integration of genetic information will be the core of 'patient-centered' care."

Related Links:

Beth Israel Deaconess Medical Center
Harvard Medical School



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.